GW Capital’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
$27.9M Sell
542,340
-81,350
-13% -$4.04M 1.93% 12
2015
Q3
$28.2M Sell
623,690
-40,428
-6% -$1.91M 1.83% 15
2015
Q2
$30.7M Sell
664,118
-35,720
-5% -$1.56M 1.64% 19
2015
Q1
$30M Sell
699,838
-348,569
-33% -$13.3M 1.38% 28
2014
Q4
$36.4M Sell
1,048,407
-230,258
-18% -$7.64M 1.68% 19
2014
Q3
$41.4M Sell
1,278,665
-64,274
-5% -$2.15M 1.76% 15
2014
Q2
$45.5M Sell
1,342,939
-202,486
-13% -$6.49M 1.75% 18
2014
Q1
$42.1M Buy
1,545,425
+20,282
+1% +$603K 1.63% 25
2013
Q4
$54.6M Sell
1,525,143
-40,962
-3% -$1.36M 2.39% 4
2013
Q3
$47.2M Sell
1,566,105
-84,218
-5% -$2.75M 2.22% 8
2013
Q2
$48.1M Buy
+1,650,323
New +$46.5M 2.44% 6

Other funds holding PBH

GW Capital's PBH Position: Q4 2015 in Review

GW Capital reduced its Prestige Consumer Healthcare (PBH) stake by 13% in Q4 2015, selling an estimated $4.04M and leaving 542,340 shares worth $27.9M. The position accounts for 1.93% of the portfolio, ranked #12.

GW Capital first reported a position in PBH in Q2 2013 and has held it in 11 quarters since. The position peaked at $54.6M in Q4 2013. 235 funds tracked by Wall St. Rank hold PBH as of Q4 2015.

  • GW Capital held 542,340 shares of Prestige Consumer Healthcare worth $27.9M as of Q4 2015.
  • GW Capital sold 81,350 Prestige Consumer Healthcare shares in Q4 2015, an estimated $4.04M.
  • Prestige Consumer Healthcare made up 1.93% of GW Capital's portfolio in Q4 2015, its #12 holding.
  • GW Capital first reported a position in Prestige Consumer Healthcare in Q2 2013 and has held it in 11 quarters since.
  • GW Capital's Prestige Consumer Healthcare position peaked at $54.6M in Q4 2013.
  • 235 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q4 2015.

Based on GW Capital's 13F filing for Q4 2015, filed 19 Feb 2016.